2024 – A Year in Review

Vivekanand Jha

doi:10.25259/IJN_821_2024

View/Download PDF

Buy Reprints

PDF

Translate this page into:

Editorial

35 (

1

); 1-2

doi:

10.25259/IJN_821_2024

2024 – A Year in Review

Vivekanand Jha^1,

1Department of Nephrology, George Institute for Global Health, Jasola, New Delhi, Delhi, India

Corresponding author: Vivekanand Jha, Department of Nephrology, George Institute for Global Health, Jasola, New Delhi, Delhi, India. E-mail: vjha@georgeinstitute.org.in

Received: 2024-12-30, Accepted: 2024-12-30, Published: 2025-01-04

Licence

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

How to cite this article: Jha V. 2024 – A Year in Review. Indian J Nephrol. 2025;35:1-2. doi: 10.25259/IJN_821_2024

As we transition to a new year, this is time to reflect upon the year gone by and evaluate the status of the Indian Journal of Nephrology (IJN), the official publication of the Indian Society of Nephrology, in its quest to serve as a vital platform for disseminating high-quality research in nephrology relevant to the kidney health community in India and around the world.

A notable development in 2024 was the change in IJN’s publishing partnership from Wolters Kluwer Medknow to Scientific Scholar.¹ This shift is aimed at enhancing accessibility and streamlining the editorial process, leading to improved user experience and ensuring continued excellence in publishing peer-reviewed research.

The journal maintained its bi-monthly publication schedule, featuring a diverse array of articles that addressed pressing issues in nephrology.

The journal published several high-impact reviews authored by global experts in the field, commissioned by the journal’s editorial board. These covered practical topics of contemporary interest such as Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,² IgA nephropathy: both disease mechanisms³ and advances in therapy,⁴ membranous nephropathy,⁵ diagnostic utility of urine microscopy⁶ and therapies for arteriovenous fistula and graft dysfunction.⁷

We published a series of articles discussing issues related to kidney transplantation, ranging from ethical issues pertaining to the role of transplant professionals in transplant commercialism in India,⁸ the growing experience of ABO-incompatible transplants,⁹ the use of induction immunosuppression in low-risk living donor transplants,¹⁰ the understanding of asymptomatic bacteriuria in kidney transplant recipients,¹¹ and the promise held by emerging therapeutic approaches such as imlifidase.¹²

Articles addressing pediatric nephrology emphasized innovations in critical care and diagnostics, reflecting a growing focus on improving outcomes for children with kidney diseases. Notable ones included a variety of issues relating to management of children with difficult-to-treat nephrotic syndrome^13-15 and publication of guidelines for the treatment of children with urinary tract infection and vesicoureteric reflux.¹⁶

Issues of practical importance were highlighted, such as the role of desmopressin acetate before kidney biopsy in reducing bleeding risk in patients with kidney dysfunction,¹⁷ checking the adequacy of kidney biopsy samples with a smartphone camera,¹⁸ and glomerular diameter measurements for patients with IgA nephropathy.¹⁹

Chronic Kidney Disease of Unknown Etiology and its possible link with environmental factors are emerging as a significant public health problem in India - as shown in reports from Chhattisgarh²⁰ and Odisha²¹ - highlighting the need for more research and advocacy on this topic.

The Journal is committed to welcoming submissions from allied healthcare professionals, as reflected in articles by renal nurses, specifically relating to an audit of assisting kidney biopsy procedures²² and the effectiveness of yoga and meditation on quality of life among hemodialysis patients.²³

The journal continued its tradition of publishing unique case reports, such as kidney disease associated with filaria,^24,25 highlighting parasitic infections’ impact on kidney health.

With an impact factor of 0.8 as reported by Clarivate Analytics and a Scopus CiteScore of 1.4, IJN continued to hold its position as a reputable journal indexed in major databases such as PubMed Central, SCOPUS, and Web of Science. Its open-access model ensured that cutting-edge research reached a wide audience, including clinicians, researchers, and policymakers.

As IJN moves into 2025, it is well-positioned to build on its legacy of excellence. The journal’s emphasis on regional challenges, ethical issues, and innovative therapies ensures its relevance in addressing both local and global nephrology concerns.

In summary, the IJN continued its journey of progress in 2024. Through its diverse publications, IJN not only advanced scientific knowledge but also fostered critical conversations about improving kidney care delivery across India and beyond. We look forward to receiving high-quality submissions to the journal to fulfill the mission of its parent society.

In addition to the contributors, special thanks are due to all the editors and reviewers for their contributions to elevating the quality of the work published in the journal. You make time to do this voluntary work for the journal and we are grateful.

We welcome feedback – both laudatory and critical, as we believe it is only in this environment of open dialogue, discussion, and argumentation for which Indian institutions have been well-known since ancient times. I look forward to an even more exciting and fruitful 2025 for the journal.

Conflicts of interest

There are no conflicts of interest.

References

Duttagupta S. The journey of indian journal of nephrology. Indian J Nephrol. 2024;34:4-5.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Roper T, Salama AD. ANCA-associated vasculitis: Practical issues in management. Indian J Nephrol. 2024;34:6-23.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Roberts LE, Williams CEC, Oni L, Barratt J, Selvaskandan H. IgA nephropathy: emerging mechanisms of disease. Indian J Nephrol. 2024;34:297-309.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Mathur M, Sahay M, Pereira BJG, Rizk DV. State-of-art therapeutics in IgA nephropathy. Indian J Nephrol. 2024;34:417-30.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Efe O, So PNH, Anandh U, Lerma EV, Wiegley N. An updated review of membranous nephropathy. Indian J Nephrol. 2024;34:105-18.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Gaggar P, Raju SB. Diagnostic utility of urine microscopy in kidney diseases. Indian J Nephrol. 2024;34:213-21.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Vachharajani TJ, Bhargava V, Sequeira A, Meena P. Existing and evolving therapies for arteriovenous fistula and graft dysfunction. Indian J Nephrol. 2024;34:552-60.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Nagral S. Transplant professionals and transplant commercialism in India: The Difficulty of Being Good. Indian J Nephrol. 2024;34:549-51.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Pawar N, Tiwari V, Gupta A, Divyaveer S, Rather I, Chadha S, Bhargava V, Malik M, Gupta A, Bhalla AK, Rana DS, Gupta P. ABO-incompatible renal transplant: A single-center experience from India. Indian J Nephrol. 2024;34:24-30.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Jha PK, Bansal SB, Sharma R, Sethi SK, Bansal D, Nandwani A, Kher A, Yadav DK, Gadde A, Mahapatra AK, Rana AS, Sodhi P, Jain M, Kher V. Role of induction in a haplomatch, related, low-risk, living-donor kidney transplantation with triple drug immunosuppression: A single-center study. Indian J Nephrol. 2024;34:246-51.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Mani SSR, Thomas A, Alam R, Lalwani M, Valson AT, Yadav B, Eapen JJ, John EE, Yusuf S, Mukha RP, Rajadoss MKP, Mercy D, Alexander S, Varughese S, David VG. Profile, risk factors, and outcomes of asymptomatic bacteriuria in kidney transplant recipients with normal pretransplant genitourinary tract: A single-center experience. Indian J Nephrol. 2024;34:37-44.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Krishnan N, Briggs D. Imlifidase: Is it the magic wand in renal transplantation? Indian J Nephrol. 2024;34:291-6.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Gaur S, Paul PP, Motamarri M. Rituximab/Mycophenolate combination therapy in children with calcineurin inhibitor-resistant FSGS. Indian J Nephrol. 2024;34:45-9.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Yadav D, Mantan M, Mahajan B. Comparison of urinary beta-2 microglobulin levels in children with SSNS and calcineurin inhibitor-treated SRNS. Indian J Nephrol. 2024;34:149-54.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Deepthi RV, Arumadi M, Eriyat V, Mathew SK, Mathew BS, Agarwal I, Prabha R. Exposure to Mycophenolic acid and its clinical response in an indian pediatric population with nephrotic syndrome. Indian J Nephrol. 2024;34:323-7.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Meena J, Bagga A, Hari P. Management of Urinary Tract Infections and Vesicoureteric Reflux: Key Updates from revised indian society of pediatric nephrology guidelines 2023. Indian J Nephrol. 2024;34:442-7.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Sethi J, Bansal S, Lal A, Kohli HS, Rathi M. Role of Desmopressin acetate before percutaneous ultrasound-guided kidney biopsy in patients with kidney dysfunction. Indian J Nephrol. 2024;34:228-32.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Modi SS, Ramamurthy S, Balasubramanian S, Kumar S, Daruwala F. Bedside method to check the adequacy of kidney biopsy sample with a smartphone camera and macro lenses: a prospective cohort study. Indian J Nephrol. 2024;34:233-6.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Manocha A, Fathima N, Gowrishankar S. Glomerular diameter measurements on light microscopy: A new parameter available to pathologists and its utility in IgA nephropathy. Indian J Nephrol. 2024;34:344-9.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Galhotra A, Rathore V, Pal R, Nayak S, Ramasamy S, Patel S, Joshi P, Nagarkar NM, Jha V. Clinico-epidemiological profile of patients with chronic kidney diseases of unknown etiology: A hospital-based, cross-sectional study from central india. Indian J Nephrol. 2024;34:241-5.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Biswas P, Sahu AK, Nath SR, Mir SA, Naik PK, Kariali E, Nayak B, Shristi S, Nayak SK, Baitharu I. Prevalence of chronic kidney disease and its association with pesticide exposure in Bargarh district, Odisha, India. Indian J Nephrol. 2024;34:467-74.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Thakur M, Mawar S, Murry LL, Sharma DK. Clinical audit of assisting renal biopsy procedure performed in nephrology unit of a tertiary care hospital with a view to develop standard nursing procedure protocol. Indian J Nephrol. 2024;34:328-31.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Parekh AJ, Prakasam A. Effectiveness of yoga and meditation on quality of life among patients undergoing hemodialysis. Indian J Nephrol. 2024;34:533-6.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Badge R, Rathore V, Aggarwal J. Filariasis-associated secondary membranous nephropathy: A rare presentation. Indian J Nephrol. 2024;34:385-7.
[CrossRef] [PubMed] [PubMed Central] [Google Scholar]
Prasad P, Gupta N, Verma R, Prasad N, Kaul A, Agrawal V, Jain M. Caught by surprise - microfilaria in renal biopsies. Indian J Nephrol. 2024;34:257-60.
[CrossRef] [PubMed] [Google Scholar]

Fulltext Views
247

PDF downloads
257

View/Download PDF
Download Citations

BibTeX
RIS

Show Sections

2024 – A Year in Review

Conflicts of interest

References

Suggested read for related articles: